Heart failure & cardiomyopathies

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy

Circ Heart FailPublished Randomised controlled trial

  • terminated after planned interim analysis suggested futility
  • Terminated after a planned interim analysis suggested futility

Authors' conclusion

Findings from REALM-DCM demonstrated futility without safety concerns.

Study context

Population
Symptomatic LMNA-related dilated cardiomyopathy: NYHA class II/III, LVEF ≤50%, ICD, reduced 6-minute walk distanceaged 23–72 years
Participants
77 participants
Comparison
ARRY-371797 400 mg twice daily vs placebo
  • ARRY-371797n = 40
  • Placebon = 37reference
Primary endpoint
Change from baseline in 6-minute walk test distance
Follow-up
Week 24
Methodological detailsphase 3, multinational, double-blind, placebo-controlled, Enrolment April 2018 to October 2022
  • Phase 3
  • Multinational
  • Double-blind
  • Placebo-controlled
  • Enrolment April 2018 to October 2022

Primary result

As reported in the abstract

Change in 6-minute walk test distance

No significant difference between groups; median difference

4.9 m

95% CI −24.2 to 34.1; P=0.82

Secondary outcomes

Change in KCCQ physical limitation score · week 24

No significant difference between groups
2.4 (95% CI −6.4 to 11.2; P=0.54)

Change in KCCQ total symptom score · week 24

No significant difference between groups
5.3 (95% CI −4.3 to 14.9; P=0.48)

Change in NT-proBNP concentration · week 24

No significant difference between groups
−339.4 pg/mL (95% CI −1131.6 to 452.7; P=0.17)

Composite of worsening HF or all-cause mortality

Similar between groups; HR
0.43 (95% CI 0.11-1.74; P=0.23)

Overall survival

Similar between groups; HR
1.19 (95% CI 0.23-6.02; P=0.84)

Original publication

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy. Circ Heart Fail. Published 9 July 2024. doi:10.1161/circheartfailure.123.011548

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.